Stem Cell Stocks 7/12/09: The Past Two Weeks

The overall market is continuing its slide. Most people are waiting to see how it responds at key technical points of 850 on the S&P and 8000 on the DOW. Meanwhile, i've been interested to see how the stem cell stocks perform. It was one of the few sectors that performed well when market initially tanked at the end of 2008. However, overall there hasn't been a repeat performance.

Top Stem Cell Stock Performer(s) the Last Two Weeks:

- BioTime Inc. (BTIM.OB) = Up 37%; A stem cell marketing agreement was announce by Biotime with Millipore. The price rose on 5 times the average daily volume. This stock has a history of spiking then falling quickly. I wouldn't recommend chasing.

Worst Stem Cell Stock Performer(s) the Last Two Weeks:

-Advanced Cell Technology (ACTC.OB) = Down -36%; After a huge move 2 weeks ago, ACTC.OB was unable to break out of that 25-30 cents range. Once it failed, it made for a great short opportunity. It's hard to say when the freefall will end.

Stem Cell Stocks Current Price and % Up or Down 6/29/09 - 7/10/09

Market Cap Over 50 Million

Ariad Pharmaceuticals (ARIA) = Cur Price: $1.54; Down -7%
Aastrom Biosciences (ASTM) = Cur Price: $0.375; Down -6%
BioTime, Inc. (BTIM.OB) = Cur Price: $3.28; Up 37%
Celgene Corp (CELG) = Cur Price: $46.10; Down -4%
Cytori Therapeutics (CYTX) = Cur Price: $3.18; Down -19%
Geron Corp (GERN) = Cur Price: $7.32; Up 5%
ThermoGenesis (KOOL) = Cur Price: $0.565; Down-9%
Osiris Therapeutics (OSIR) = Cur Price: $11.53; Down -13%
StemCell Inc. (STEM) = Cur Price: $1.57; Down -13%

Market Cap Under 50 Million

Advanced Cell Technology (ACTC.OB) = Cur Price: $0.162; Down -36%
Athersys Inc. (ATHX) = Cur Price: $0.80; Down -4%
Brainstorm Cell Therapeutics (BCLI.OB) = Cur Price: $0.0695; Down -1%
Bioheart Inc. (BHRT) = Cur Price: $0.70; Down -18%
Cord Blood America Inc. (CBAI.OB) = Cur Price: $0.0033; Down -13%
Cyro-Cell Intl (CCEL.OB) = Cur Price: $1.42; Up 23%
Neuralstem (CUR) = Cur Price: $1.14; Down -5%
International Stem Cell (ISCO.OB) = Cur Price: $0.87; Up 9%
MultiCell Technologies (MCET.OB) = Cur Price: $0.011; Up 5%
Pluristem Therapeutics (PSTI) = Cur Price: $1.29; Up 2%
Stem Cell Therapy Intl (SCII.OB) = Cur Price: $0.05; Unchanged
Stem Cell Innovations (SCLL.PK) = Cur Price: $0.03; Down -17%

Catalyst(s):

Still, nothing has changed from the last few months.

- M&A (mergers and acquisitions) activity will be key. I can't believe that there hasn't been any activity yet, but I think it will happen as the economy improves.